FEDERATED HERMES, INC.

Position in IBRX — ImmunityBio, Inc.

CIK 1056288 PITTSBURGH, PA

Position in IBRX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$10,635,152

+$10,634,089 QoQ

Shares Held

1,386,591

+700198.5% QoQ

Ownership

0.132%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FEDERATED HERMES, INC. holds $2,357,893,949 across 146 Biotechnology names. IBRX ranks #46 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	687,816	$227,577,679
2	REGN	Regeneron Pharmaceuticals, Inc.	254,946	$196,981,475
3	RYTM	Rhythm Pharmaceuticals, Inc.	1,286,303	$111,869,771
4	MRNA	Moderna, Inc.	1,977,079	$100,435,613
5	IDYA	IDEAYA Biosciences, Inc.	2,987,107	$99,530,405
6	INSM	INSMED Inc	538,257	$88,015,784
7	CNTA	Centessa Pharmaceuticals plc	2,049,439	$81,403,717
8	EYPT	EyePoint, Inc.	5,669,589	$73,081,000

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,635,152	1,386,591	+700198.5%	Shares	Defined	2026-05-11
2024-03-31	$1,063	198	+0.5%	Shares	Defined	2024-05-14
2023-12-31	$988	197	-24.2%	Shares	Defined	2024-01-31
2023-09-30	$439	260	-98.3%	Shares	Defined	2023-11-13
2023-06-30	$43,798	15,755	-28.4%	Shares	Defined	2023-08-14
2023-03-31	$40,052	22,007	+1001.5%	Shares	Defined	2023-05-08
2022-03-31	$11,208	1,998	+0.2%	Shares	Defined	2022-05-13
2021-12-31	$12,129	1,995	-55.9%	Shares	Defined	2022-02-14
2021-09-30	$44,063	4,524	-0.7%	Shares	Defined	2021-11-15
2021-06-30	$65,088	4,558	+4854.3%	Shares	Defined	2021-08-16
2021-03-31	$2,184	92	—	Shares	Defined	2021-05-13
No filing history on record for this holder in this stock.